Ross N, Hutchinson P J, Seeley H, Kirkpatrick P J
University Department of Neurosurgery, Box 167, Block A, Level 4, Addenbrookes Hospital, Cambridge CB2 2QQ, UK.
J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):480-4. doi: 10.1136/jnnp.72.4.480.
The debate on the timing of aneurysm surgery after subarachnoid haemorrhage (SAH) pivots on the balance of the temporal risk for fatal rebleeding versus the risk of surgical morbidity when operating early on an acutely injured brain. By following a strict management protocol for SAH, the hypothesis has been tested that in the modern arena of treatment for aneurysmal SAH the timing of surgery to secure supratentorial aneurysms does not affect surgical outcome.
Over a 6 year period, patients admitted with a diagnosis of SAH to a regional neurosurgical unit have been prospectively studied. All have been on a management protocol in which early transfer and resuscitation has been followed regardless of age and clinical condition. Angiographic investigation and surgery have been pursued in those who have been able to at least flex to pain. A total of 1168 patients (60.7% female, mean age 54.3) with proved SAH were received on median day 1 (86.4% arrived within 3 days) of the ictus. Of these, 784 (67.1%) showed aneurysms on angiography and were prepared for surgery. Those who received surgery for a supratentorial aneurysm within 21 days of the ictus were included in the final analysis (n=550). Patients with an initial negative angiogram, with posterior circulation aneurysms, or aneurysms treated by endovascular means, with aneurysms requiring emergency surgery for space occupying haematomas, with aneurysms which re-bled before surgery, and those who received very late surgery (after 21 days from ictus) were excluded. Surgical outcomes at hospital discharge and after 6 months were assessed using the Glasgow outcome score (GOS). Discharge destination and duration of stay in a neurosurgical ward were also documented. The influence of the timing of surgery (early group day 1-3 postictus, intermediate group day 4-10, or late group day 11-21) was analysed prospectively.
60.2% of cases fell into the early surgery group, 32.4% into the intermediate group, and 7.5% into the late operated group. Late surgery was due to delays in diagnosis, transfer, and logistic factors, but not clinical decision. The demographic characteristics, site of aneurysm, and clinical condition of the patients at the time of initial medical assessment were balanced in the three surgical timing groups. There was no significant difference in GOS between the surgical timing groups at 6 months (favourable GOS score 4 and 5: 83.2%, 80.5%, and 83.8% respectively; p=0.47, Kruskal-Wallis test). Outcome was favourable in 84% of patients under 65 years, and 70% in those over 65. The discharge destinations (home, referring hospital, nursing home, rehabilitation centre) showed no significant difference between surgical timing groups. There was no significant difference in mean time to discharge after admission to this hospital from the referring hospital (16.2, 16.2, and 14.6 days for early, intermediate, and late groups respectively; p=0.789, Analysis of variance (ANOVA)). As a result, there was reduction in the mean duration of total hospital inpatient stay in favour of the earliest operated patients (mean time 18.1, 22.0, and 28.3 days respectively; p=0.001. ANOVA showed that besides age, the only determinant of surgical outcome and duration of stay was presenting clinical grade (p<0.0005).
The current management of patients presenting with SAH from anterior circulation aneurysms allows early surgery to be followed safely regardless of age. The only independent variables affecting outcome are age and clinical grade at presentation. The timing of surgery did not significantly affect surgical outcome, promoting a policy for early surgery that avoids the known risks of rebleeding and reduces inpatient stay.
蛛网膜下腔出血(SAH)后动脉瘤手术时机的争论主要围绕急性脑损伤早期手术时致命性再出血的时间风险与手术并发症风险之间的平衡。通过遵循严格的SAH管理方案,检验了这样一个假设:在现代动脉瘤性SAH治疗领域,确保幕上动脉瘤的手术时机不会影响手术结果。
对一家地区神经外科单位6年间诊断为SAH的患者进行了前瞻性研究。所有患者均遵循一种管理方案,无论年龄和临床状况如何,均进行早期转运和复苏。对那些至少能对疼痛产生屈曲反应的患者进行血管造影检查和手术。共有1168例确诊为SAH的患者(女性占60.7%,平均年龄54.3岁)在发病后第1天(中位数)入院(86.4%在3天内到达)。其中,784例(67.1%)血管造影显示有动脉瘤并准备手术。在发病后21天内接受幕上动脉瘤手术的患者纳入最终分析(n = 550)。排除初始血管造影阴性、后循环动脉瘤、血管内治疗的动脉瘤、因占位性血肿需要急诊手术的动脉瘤、术前再出血的动脉瘤以及接受极晚期手术(发病后21天之后)的患者。使用格拉斯哥预后评分(GOS)评估出院时及6个月后的手术结果。还记录了出院去向和在神经外科病房的住院时间。前瞻性分析了手术时机(早期组发病后第1 - 3天、中期组第4 - 10天、晚期组第11 - 21天)的影响。
60.2%的病例属于早期手术组,32.4%属于中期组,7.5%属于晚期手术组。晚期手术是由于诊断、转运和后勤因素延迟,但并非临床决策所致。三个手术时机组患者在初始医学评估时的人口统计学特征、动脉瘤部位和临床状况均衡。6个月时手术时机组之间的GOS无显著差异(良好GOS评分4和5:分别为83.2%、80.5%和83.8%;p = 0.47,Kruskal - Wallis检验)。65岁以下患者84%预后良好,65岁以上患者70%预后良好。出院去向(回家、转诊医院、养老院、康复中心)在手术时机组之间无显著差异。从转诊医院入院到本院出院的平均时间无显著差异(早期、中期和晚期组分别为16.2天、16.2天和14.6天;p = 0.789,方差分析(ANOVA))。结果,最早手术的患者总住院时间平均缩短(分别为18.1天、22.0天和28.3天;p = 0.001。ANOVA表明,除年龄外,手术结果和住院时间的唯一决定因素是就诊时的临床分级(p < 0.0005))。
目前对前循环动脉瘤所致SAH患者的管理允许安全地进行早期手术,无论年龄如何。影响结果的唯一独立变量是就诊时的年龄和临床分级。手术时机并未显著影响手术结果,这支持了早期手术的策略,该策略可避免已知的再出血风险并缩短住院时间。